- Home
- AUTL vs VREX Comparison
AUTL vs VREX Comparison
Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | VREX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 483.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | VREX |
|---|---|---|
| Price | $1.66 | $12.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.33 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 4.1M | 299.1K |
| Earning Date | 11-12-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $51,128,000.00 | ★ $844,600,000.00 |
| Revenue This Year | $658.11 | $4.79 |
| Revenue Next Year | $91.34 | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | 4.14 |
| 52 Week Low | $1.11 | $6.76 |
| 52 Week High | $2.80 | $15.46 |
Technical Indicators
Market Signals| Indicator | AUTL | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 62.05 |
| Support Level | $1.56 | $11.71 |
| Resistance Level | $1.79 | $12.54 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 57.58 | 75.22 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.